Literature DB >> 25091550

Electrocardiographic signs of left ventricular hypertrophy in obese patients: what criteria should be used?

Giuseppe Germano1.   

Abstract

Overweight and obesity are estimated at high prevalence and progression in adults; they are major contributors to chronic diseases and a major public health challenge. An obese habitus changes body-surface electrocardiograms (ECGs). Obesity is responsible for geometric changes to the heart and torso, as well as for deleterious electrophysiological changes of the heart. Common ECG changes, reduced voltages in the precordial leads, and axis deviation have made the search for left ventricular hypertrophy (LVH) even more problematic. Identification of LVH by ECG is difficult and time consuming but ECG is fundamental to reveal abnormalities of clinical relevance associated with obesity. The QTc dispersion assessment and the comparison with magnetic resonance imaging are the frontiers to clarify the connection between ECG LVH signs and overweight and obesity.

Entities:  

Mesh:

Year:  2014        PMID: 25091550     DOI: 10.1007/s40292-014-0062-3

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  29 in total

1.  2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson; Harmon S Jordan; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

2.  A point-score system for the ECG diagnosis of left ventricular hypertrophy.

Authors:  D W Romhilt; E H Estes
Journal:  Am Heart J       Date:  1968-06       Impact factor: 4.749

Review 3.  Obesity and the electrocardiogram.

Authors:  M A Fraley; J A Birchem; N Senkottaiyan; M A Alpert
Journal:  Obes Rev       Date:  2005-11       Impact factor: 9.213

4.  A standardized procedure for locating and documenting ECG chest electrode positions: consideration of the effect of breast tissue on ECG amplitudes in women.

Authors:  P M Rautaharju; L Park; F S Rautaharju; R Crow
Journal:  J Electrocardiol       Date:  1998-01       Impact factor: 1.438

5.  Heart rate-corrected QT interval duration is significantly associated with blood pressure in Chinese hypertensives.

Authors:  Shaojie Peng; Yunxian Yu; Ke Hao; Houxun Xing; Dong Li; Changzhong Chen; Aiqun Huang; Xiumei Hong; Yan Feng; Yan Zhang; Jianping Li; Binyan Wang; Di Wu; Xiaobin Wang; Xiping Xu
Journal:  J Electrocardiol       Date:  2005-11-09       Impact factor: 1.438

6.  QT dispersion in patients with different etiologies of left ventricular hypertrophy: the significance of QT dispersion in endurance athletes.

Authors:  Mehdi Zoghi; Cemil Gürgün; Oguz Yavuzgil; Azem Akilli; Cüneyt Türkoglu; Hakan Kültürsay; Mustafa Akin
Journal:  Int J Cardiol       Date:  2002-08       Impact factor: 4.164

7.  Correlation of electrocardiographic left ventricular hypertrophy criteria with left ventricular mass by echocardiogram in obese hypertensive patients.

Authors:  William da Costa; Andrés Ricardo Perez Riera; Francisco de Assis Costa; Maria Teresa Nogueira Bombig; Angelo Amato Vicenzo de Paola; Antonio Carlos Camargo Carvalho; Francisco Helfenstein Fonseca; Bráulio Luna Filho; Rui Póvoa
Journal:  J Electrocardiol       Date:  2008 Nov-Dec       Impact factor: 1.438

Review 8.  Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review.

Authors:  Daniel Pewsner; Peter Jüni; Matthias Egger; Markus Battaglia; Johan Sundström; Lucas M Bachmann
Journal:  BMJ       Date:  2007-08-28

9.  Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.

Authors:  Paolo Verdecchia; Jan A Staessen; Fabio Angeli; Giovanni de Simone; Augusto Achilli; Antonello Ganau; Gianfrancesco Mureddu; Sergio Pede; Aldo P Maggioni; Donata Lucci; Gianpaolo Reboldi
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  2 in total

1.  Seamens' Sign: a novel electrocardiogram prediction tool for left ventricular hypertrophy.

Authors:  Philip Walker; Cathy A Jenkins; Jeremy Hatcher; Clifford Freeman; Nickolas Srica; Bryant Rosell; Eriny Hanna; Cooper March; Charles Seamens; Alan Storrow; Nicole McCoin
Journal:  PeerJ       Date:  2022-05-31       Impact factor: 3.061

2.  Optimized electrocardiographic criteria for the detection of left ventricular hypertrophy in obesity patients.

Authors:  Sanne M Snelder; Sweder W E van de Poll; Lotte E de Groot-de Laat; Isabella Kardys; Felix Zijlstra; Bas M van Dalen
Journal:  Clin Cardiol       Date:  2020-01-28       Impact factor: 2.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.